-
Trending now
Dow surges on Iran deal hopes and oil drop
Dow futures – Stocks rallied as hopes for an Iran agreement grew, while oil prices slid and AMD shares jumped…
-
Trending now
Nebius Group Surge: Is NBIS Too Late to Buy?
Nebius Group – Misryoum breaks down why NBIS’s jump is drawing debate over valuation, expectations, and risk. Nebius Group’s sharp…
-
Trending now
Nebius Group Valuation Spotlight as AI Momentum Builds
Misryoum reviews why investors are rethinking Nebius Group’s pricing amid renewed AI infrastructure interest and profit expectations. Nebius Group is…
-
Trending now
Met Gala Fashion Is Art: Boldest “Wait, What?” Looks
Fashion Is – From prosthetics to marble-like sculpture, Misryoum rounds up the Met Gala’s most talked-about outfits and what made…
-
Trending now
April ETF Winners: SPY, QQQ, XSD Lead Gains
April ETF – MISRYOUM tracks April’s top ETF movers as oil, inflation worries, and earnings momentum reshaped market sentiment. April’s…
-
Trending now
CVS tops estimates and lifts 2026 outlook on Aetna strength
CVS 2026 – CVS beat first-quarter revenue and profit expectations and raised its 2026 guidance as Aetna’s insurance business continued…
-
Trending now
Disney shares rise 5% as parks and streaming lift results
Disney earnings – Disney’s latest quarterly report beat expectations, lifted by experiences revenue and a resilient streaming business, sending shares…
-
Trending now
Disney shares rise 5% as parks and streaming lift results
Disney earnings – Disney’s latest quarterly report beat expectations, lifted by experiences revenue and a resilient streaming business, sending shares…
-
Trending now
Oil Prices Slide as Iran–China Talks Signal Renewed Leverage
Iran talks – Oil prices fell amid shifting Iran–US pressure and renewed Iran–China diplomacy ahead of Trump’s China visit. Oil…
-
Trending now
Wegovy pill sales lift Novo Nordisk stock
Misryoum reports Novo Nordisk’s oral Wegovy pill outperformed early expectations, lifting shares and raising 2026 guidance. A weight-loss pill is…
